HRP20010940B1 - Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations - Google Patents

Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations

Info

Publication number
HRP20010940B1
HRP20010940B1 HR20010940A HRP20010940A HRP20010940B1 HR P20010940 B1 HRP20010940 B1 HR P20010940B1 HR 20010940 A HR20010940 A HR 20010940A HR P20010940 A HRP20010940 A HR P20010940A HR P20010940 B1 HRP20010940 B1 HR P20010940B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparations
gastric fluid
obtaining same
microgranules
insoluble
Prior art date
Application number
HR20010940A
Other languages
English (en)
Inventor
Bruno Criere
Pascal Suplie
Pascal Oury
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9545866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010940(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of HRP20010940A2 publication Critical patent/HRP20010940A2/hr
Publication of HRP20010940B1 publication Critical patent/HRP20010940B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20010940A 1999-05-21 2001-12-20 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations HRP20010940B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906479A FR2793688B1 (fr) 1999-05-21 1999-05-21 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR2000/001367 WO2000071121A1 (fr) 1999-05-21 2000-05-19 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
HRP20010940A2 HRP20010940A2 (en) 2003-02-28
HRP20010940B1 true HRP20010940B1 (en) 2004-10-31

Family

ID=9545866

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010940A HRP20010940B1 (en) 1999-05-21 2001-12-20 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations

Country Status (35)

Country Link
US (1) US8409612B1 (cs)
EP (1) EP1178799B1 (cs)
JP (2) JP5344781B2 (cs)
KR (1) KR100603915B1 (cs)
CN (1) CN1243546C (cs)
AR (1) AR024036A1 (cs)
AT (1) ATE247960T1 (cs)
AU (1) AU771759B2 (cs)
BG (1) BG65415B1 (cs)
BR (1) BR0010832A (cs)
CA (1) CA2373972C (cs)
CZ (1) CZ302946B6 (cs)
DE (1) DE60004815T2 (cs)
DK (1) DK1178799T3 (cs)
EA (1) EA003943B1 (cs)
EE (1) EE04902B1 (cs)
ES (1) ES2204598T3 (cs)
FR (1) FR2793688B1 (cs)
GE (1) GEP20053580B (cs)
HK (1) HK1042851B (cs)
HR (1) HRP20010940B1 (cs)
HU (1) HU227590B1 (cs)
IL (2) IL146484A0 (cs)
IS (1) IS2160B (cs)
MX (1) MXPA01011973A (cs)
NO (1) NO331643B1 (cs)
PL (1) PL198355B1 (cs)
PT (1) PT1178799E (cs)
RS (1) RS50241B (cs)
SI (1) SI1178799T1 (cs)
SK (1) SK287605B6 (cs)
TR (1) TR200103325T2 (cs)
UA (1) UA72522C2 (cs)
WO (1) WO2000071121A1 (cs)
ZA (1) ZA200109472B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
EP3106150B1 (en) 2013-12-04 2021-07-28 Boehringer Ingelheim Vetmedica GmbH Improved pharmaceutical compositions of pimobendan
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
US5654009A (en) * 1991-03-25 1997-08-05 Fujisawa Pharmaceutical Co., Ltd. Delayed action preparation
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
FR2692146B1 (fr) 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
NZ282804A (en) * 1994-03-18 2000-12-22 Hans Jurgen Upmeyer Use of dimethylpolysiloxane (dimeticone) for treating helicobacter pylori infections
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
CA2197327A1 (en) * 1994-09-30 1996-04-11 Shigeyuki Takada Oral sustained-release preparation
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
PL186605B1 (pl) 1995-09-21 2004-01-30 Pharma Pass Llc Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
JPH1029937A (ja) * 1996-05-15 1998-02-03 Kobayashi Seiyaku Kogyo Kk メフェナム酸水溶液製剤
ATE271379T1 (de) 1996-11-06 2004-08-15 Wockhardt Europ Ltd System zur verzögerten freisetzung säurelabiler substanzen
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
ATE500815T1 (de) * 1997-12-08 2011-03-15 Dietrich Rango Neue suppositoriumsform mit säureempfindlichem wirkstoff
SE9704869D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
FR2774288B1 (fr) * 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Also Published As

Publication number Publication date
ES2204598T3 (es) 2004-05-01
TR200103325T2 (tr) 2002-05-21
EA200101221A1 (ru) 2002-04-25
SI1178799T1 (en) 2003-12-31
CN1243546C (zh) 2006-03-01
HUP0201304A3 (en) 2007-11-28
JP2003500358A (ja) 2003-01-07
RS50241B (sr) 2009-07-15
HK1042851A1 (en) 2002-08-30
HRP20010940A2 (en) 2003-02-28
IL146484A (en) 2006-04-10
PT1178799E (pt) 2004-01-30
PL198355B1 (pl) 2008-06-30
AU4765300A (en) 2000-12-12
HK1042851B (zh) 2004-01-30
KR20020011990A (ko) 2002-02-09
FR2793688B1 (fr) 2003-06-13
JP2011157390A (ja) 2011-08-18
IS2160B (is) 2006-11-15
CN1351494A (zh) 2002-05-29
HUP0201304A2 (en) 2002-08-28
FR2793688A1 (fr) 2000-11-24
CZ20014155A3 (cs) 2002-04-17
BG65415B1 (bg) 2008-07-31
DK1178799T3 (da) 2003-12-22
EA003943B1 (ru) 2003-10-30
BG106102A (en) 2002-07-31
GEP20053580B (en) 2005-07-25
WO2000071121A1 (fr) 2000-11-30
ATE247960T1 (de) 2003-09-15
DE60004815D1 (de) 2003-10-02
IS6151A (is) 2001-11-08
AR024036A1 (es) 2002-09-04
EE04902B1 (et) 2007-10-15
EP1178799A1 (fr) 2002-02-13
CA2373972C (fr) 2011-07-12
HU227590B1 (hu) 2011-09-28
YU82301A (sh) 2004-07-15
IL146484A0 (en) 2002-07-25
NO20015480L (no) 2002-01-10
EP1178799B1 (fr) 2003-08-27
NO20015480D0 (no) 2001-11-08
MXPA01011973A (es) 2002-05-06
BR0010832A (pt) 2002-03-05
EE200100615A (et) 2003-02-17
CZ302946B6 (cs) 2012-01-25
DE60004815T2 (de) 2004-06-17
JP5344781B2 (ja) 2013-11-20
KR100603915B1 (ko) 2006-07-24
SK16322001A3 (sk) 2002-05-09
ZA200109472B (en) 2002-08-07
UA72522C2 (en) 2005-03-15
WO2000071121A9 (fr) 2002-05-23
AU771759B2 (en) 2004-04-01
US8409612B1 (en) 2013-04-02
SK287605B6 (sk) 2011-03-04
PL351658A1 (en) 2003-05-19
CA2373972A1 (fr) 2000-11-30
NO331643B1 (no) 2012-02-13

Similar Documents

Publication Publication Date Title
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
AU1632601A (en) System and method for pharmacy administration
HUP0105478A3 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HK1020949A1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
PL351658A1 (en) Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HK1036402A1 (en) Morphine sulphate microgranules, method for makingsame and pharmaceutical preparations.
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
MXPA01011611A (es) Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
SI1169032T1 (sl) Mikrogranule ketoprofena, postopek izdelave in farmacevtska zmes
AU4302200A (en) Ketoprofen microgranules, preparation method and pharmaceutical compositions
GB0002342D0 (en) Apparatus and method for drug administration

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: ETHYPHARM, FR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20140428

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20150519